BR9916328A - Inibidores de transferase de farnesila - Google Patents
Inibidores de transferase de farnesilaInfo
- Publication number
- BR9916328A BR9916328A BR9916328-4A BR9916328A BR9916328A BR 9916328 A BR9916328 A BR 9916328A BR 9916328 A BR9916328 A BR 9916328A BR 9916328 A BR9916328 A BR 9916328A
- Authority
- BR
- Brazil
- Prior art keywords
- transferase inhibitors
- farnesyl transferase
- compounds
- disclosed
- farnesyl
- Prior art date
Links
- 239000003528 protein farnesyltransferase inhibitor Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 102000004357 Transferases Human genes 0.000 abstract 1
- 108090000992 Transferases Proteins 0.000 abstract 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000004030 farnesyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000565 sulfonamide group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21656098A | 1998-12-18 | 1998-12-18 | |
| PCT/US1999/027938 WO2000037458A1 (en) | 1998-12-18 | 1999-12-16 | Farnesyl protein transferase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9916328A true BR9916328A (pt) | 2001-10-02 |
Family
ID=22807539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9916328-4A BR9916328A (pt) | 1998-12-18 | 1999-12-16 | Inibidores de transferase de farnesila |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1140904B1 (OSRAM) |
| JP (1) | JP2002533335A (OSRAM) |
| KR (1) | KR20010081115A (OSRAM) |
| CN (1) | CN1285588C (OSRAM) |
| AR (1) | AR021716A1 (OSRAM) |
| AT (1) | ATE293622T1 (OSRAM) |
| AU (1) | AU2347900A (OSRAM) |
| BR (1) | BR9916328A (OSRAM) |
| CA (1) | CA2354774C (OSRAM) |
| CO (1) | CO5160344A1 (OSRAM) |
| CZ (1) | CZ20011900A3 (OSRAM) |
| DE (1) | DE69924876T2 (OSRAM) |
| ES (1) | ES2237963T3 (OSRAM) |
| HU (1) | HUP0203054A3 (OSRAM) |
| ID (1) | ID29065A (OSRAM) |
| IL (1) | IL143409A0 (OSRAM) |
| NO (1) | NO20012960L (OSRAM) |
| PE (1) | PE20001516A1 (OSRAM) |
| PL (1) | PL348294A1 (OSRAM) |
| SK (1) | SK7582001A3 (OSRAM) |
| TR (1) | TR200101754T2 (OSRAM) |
| WO (1) | WO2000037458A1 (OSRAM) |
| ZA (1) | ZA200104236B (OSRAM) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60036568T2 (de) * | 1999-11-10 | 2008-06-26 | Sanofi-Aventis Deutschland Gmbh | N-acylpyrrolidin-2-ylalkylbenzamidin-derivate als inhibitoren von factor xa |
| US7361663B2 (en) | 1999-11-10 | 2008-04-22 | Aventis Pharmaceuticals Inc. | N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa |
| US6589978B2 (en) * | 2000-06-30 | 2003-07-08 | Hoffman-La Roche Inc. | 1-sulfonyl pyrrolidine derivatives |
| US7342016B2 (en) | 2000-08-30 | 2008-03-11 | Schering Corporation | Farnesyl protein transferase inhibitors as antitumor agents |
| AR033680A1 (es) * | 2000-08-30 | 2004-01-07 | Schering Corp | Compuestos triciclicos utiles como inhibidores de la farnesil proteino transferasa y su uso para la manufactura de medicamentos como agentes antitumorales |
| US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| US6376514B1 (en) | 2000-10-17 | 2002-04-23 | The Procter & Gamble Co. | Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof |
| US6809093B2 (en) | 2000-10-17 | 2004-10-26 | H. Lee Moffitt Cancer & Research Institute, Inc. | 2-substituted heterocyclic compounds |
| AU2002236813A1 (en) * | 2001-01-22 | 2002-07-30 | Schering Corporation | Treatment of malaria with farnesyl protein transferase inhibitors |
| ATE412638T1 (de) | 2001-02-16 | 2008-11-15 | Aventis Pharma Inc | Heterocyclische substituierte carbonyl derivate und ihre verwendung als dopamin d3 rezeptor liganden |
| AU2002257114A1 (en) * | 2001-04-06 | 2002-10-21 | Schering Corporation | Treatment of malaria with farsenyl protein transferase inhibitors |
| FR2825705B1 (fr) * | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
| GB0115862D0 (en) | 2001-06-28 | 2001-08-22 | Smithkline Beecham Plc | Compounds |
| US6740757B2 (en) * | 2001-08-29 | 2004-05-25 | Pfizer Inc | Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer |
| FR2835186B1 (fr) | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
| FR2844273B1 (fr) | 2002-09-05 | 2008-04-04 | Aventis Pharma Sa | Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens. |
| AU2003293555A1 (en) * | 2002-12-17 | 2004-07-29 | Schering Corporation | 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| US7585864B2 (en) * | 2004-12-13 | 2009-09-08 | Schering Corporation | Farnesyl protein transferase inhibitors and their use to treat cancer |
| EP1833481A1 (en) | 2004-12-14 | 2007-09-19 | Schering Corporation | Farnesyl protein transferase inhibitors and methods for treating proliferative diseases |
| CA2637572A1 (en) * | 2006-01-19 | 2007-07-26 | Schering Corporation | Piperazine derivatives as farnesyl protein transferase inhibitors |
| CA2724648A1 (en) * | 2008-05-22 | 2009-11-26 | Merck Sharp & Dohme Corp. | Process for the preparation of an orexin receptor antagonist |
| HU231150B1 (hu) | 2017-03-13 | 2021-03-29 | Richter Gedeon Nyrt | Eljárás racém 3-alkilpiperidin-3-karbonsav-etil-észterek optikai izomerjeinek elválasztására |
| AU2020286381C1 (en) | 2019-06-04 | 2025-07-10 | Hager Biosciences, Llc | Imidazolo derivatives, compositions and methods as orexin antagonists |
| TWI907472B (zh) | 2020-08-05 | 2025-12-11 | 匈牙利商羅特格登公司 | 具藥理活性之經雜環取代的吡唑并〔１，５－ａ〕嘧啶衍生物 |
| CN114349711B (zh) * | 2022-02-28 | 2023-08-15 | 四川依维欣医药科技有限公司 | 一种（R）-1-Boc-3-羟甲基哌嗪的合成方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL111235A (en) * | 1993-10-15 | 2001-03-19 | Schering Plough Corp | Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them |
| GB9420172D0 (en) * | 1994-10-06 | 1994-11-23 | Boots Co Plc | Therapeutic agents |
| IL117798A (en) * | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
| KR100640672B1 (ko) * | 1997-06-17 | 2006-11-02 | 파마코페이아 드럭 디스커버리, 인크. | 파르네실 단백질 트랜스퍼라제의 억제에 유용한 벤즈피리도 사이클로헵탄 화합물 및 이를 포함하는 약제학적 조성물 |
-
1999
- 1999-12-16 AT AT99967139T patent/ATE293622T1/de not_active IP Right Cessation
- 1999-12-16 SK SK758-2001A patent/SK7582001A3/sk unknown
- 1999-12-16 KR KR1020017007535A patent/KR20010081115A/ko not_active Withdrawn
- 1999-12-16 EP EP99967139A patent/EP1140904B1/en not_active Expired - Lifetime
- 1999-12-16 ID IDW00200101310A patent/ID29065A/id unknown
- 1999-12-16 CN CNB998162078A patent/CN1285588C/zh not_active Expired - Fee Related
- 1999-12-16 CZ CZ20011900A patent/CZ20011900A3/cs unknown
- 1999-12-16 CO CO99078838A patent/CO5160344A1/es unknown
- 1999-12-16 TR TR2001/01754T patent/TR200101754T2/xx unknown
- 1999-12-16 BR BR9916328-4A patent/BR9916328A/pt not_active IP Right Cessation
- 1999-12-16 HU HU0203054A patent/HUP0203054A3/hu unknown
- 1999-12-16 PL PL99348294A patent/PL348294A1/xx not_active Application Discontinuation
- 1999-12-16 AR ARP990106459A patent/AR021716A1/es unknown
- 1999-12-16 DE DE69924876T patent/DE69924876T2/de not_active Expired - Fee Related
- 1999-12-16 AU AU23479/00A patent/AU2347900A/en not_active Abandoned
- 1999-12-16 ES ES99967139T patent/ES2237963T3/es not_active Expired - Lifetime
- 1999-12-16 IL IL14340999A patent/IL143409A0/xx unknown
- 1999-12-16 WO PCT/US1999/027938 patent/WO2000037458A1/en not_active Ceased
- 1999-12-16 JP JP2000589530A patent/JP2002533335A/ja active Pending
- 1999-12-16 CA CA002354774A patent/CA2354774C/en not_active Expired - Fee Related
- 1999-12-17 PE PE1999001293A patent/PE20001516A1/es not_active Application Discontinuation
-
2001
- 2001-05-23 ZA ZA200104236A patent/ZA200104236B/en unknown
- 2001-06-15 NO NO20012960A patent/NO20012960L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1285588C (zh) | 2006-11-22 |
| JP2002533335A (ja) | 2002-10-08 |
| SK7582001A3 (en) | 2002-03-05 |
| ATE293622T1 (de) | 2005-05-15 |
| CZ20011900A3 (cs) | 2002-02-13 |
| CO5160344A1 (es) | 2002-05-30 |
| PL348294A1 (en) | 2002-05-20 |
| EP1140904B1 (en) | 2005-04-20 |
| CN1352642A (zh) | 2002-06-05 |
| KR20010081115A (ko) | 2001-08-27 |
| HUP0203054A2 (hu) | 2003-01-28 |
| PE20001516A1 (es) | 2001-01-06 |
| ES2237963T3 (es) | 2005-08-01 |
| CA2354774C (en) | 2009-05-26 |
| NO20012960L (no) | 2001-08-15 |
| EP1140904A1 (en) | 2001-10-10 |
| IL143409A0 (en) | 2002-04-21 |
| WO2000037458A1 (en) | 2000-06-29 |
| ZA200104236B (en) | 2002-08-23 |
| DE69924876D1 (de) | 2005-05-25 |
| ID29065A (id) | 2001-07-26 |
| DE69924876T2 (de) | 2006-03-02 |
| HUP0203054A3 (en) | 2004-01-28 |
| NO20012960D0 (no) | 2001-06-15 |
| TR200101754T2 (tr) | 2002-05-21 |
| HK1036279A1 (en) | 2001-12-28 |
| AR021716A1 (es) | 2002-07-31 |
| AU2347900A (en) | 2000-07-12 |
| CA2354774A1 (en) | 2000-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9907429A (pt) | Composto de hidrazida, processo para sua preparação e composições farmacêuticas contendo os mesmos | |
| TR200101754T2 (tr) | Farnezil protein transferaz inhibitörleri | |
| ATE177420T1 (de) | Cyclobutan-derivate als inhibitoren der squalen- synthetase und der protein-farnesyltransferase | |
| BR9806752A (pt) | Ftalazinonas. | |
| ATE423557T1 (de) | Carbocyclische kaliumkanalhemmer | |
| EP1379251A4 (en) | INGREDIENTS OF THE ACT ACTIVITY | |
| EP1089724A4 (en) | THERAPEUTIC COMPOSITIONS AND METHOD AND ITS USE | |
| EP1631548A4 (en) | HEMMER OF ACT ACTIVITY | |
| CY1105912T1 (el) | Αναστολεις συγκολλησης κυτταρου | |
| BR9706792A (pt) | Derivado de tiazol | |
| BR9812564A (pt) | Amidas de ácido acilsulfamoilbenzóico, agentes protetores de plantas úteis contendo as mesmas e processos para a sua preparação | |
| BR9911783A (pt) | Compostos cìclicos substituìdos, processo para sua preparação e composições farmacêuticas que os contêm | |
| FI20030162A7 (fi) | Uusia yhdisteitä | |
| BR0315143A (pt) | Composto, processo para a preparação dos (r) e (s) - enanciÈmeros individuais ou misturas de enanciÈmeros e sais farmaceuticamente aceitáveis de um composto, composição farmacêutica, e, uso de um composto | |
| BR0110745A (pt) | Compostos de piperazinadiona | |
| ATE290382T1 (de) | Heterozyklische kalium-kanal inhibitoren | |
| BR9909781A (pt) | Composto de formula (i), processo para sua preparação, composição farmacêutica compreendendo dito composto, seu uso e método. | |
| ATE232873T1 (de) | Phosphonsaürederivate als ptp-1b-inhibitoren | |
| BR0112093A (pt) | Derivados de sulfonil-pirrolidina úteis no tratamento de distúrbios neurológicos | |
| BR9914355A (pt) | Derivados de mononitrato de isosorbida e sua utilização como agentes vasodilatadores com tolerância reduzida | |
| DE69819525D1 (de) | Acridine derivate zur verbesserung der oralen bioverfügbarkeit von taxol | |
| BR0013292A (pt) | Derivados de benzenamina como anti-coagulantes | |
| BR9909870A (pt) | Pirrolidinas como inibidores de neuraminidases | |
| BR9916314A (pt) | Inibidores tricìclicos da proteìna farnesil transferase | |
| BR9904951A (pt) | Compostos cìclicos tendo uma cadeia cicloalquileno, processo para sua preparação e composições farmacêuticas contendo os mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5O, 6O E 7O ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007. |